Premiums In Plans That Cap Insulin Costs Double Those That Don’t

By John Wilkerson / March 31, 2022 at 5:09 PM
Premiums in Medicare plans that cap monthly out-of-pocket insulin costs are nearly twice that of plans that don’t cap costs, according to a Kaiser Family Foundation analysis. The House was poised on Thursday (March 31) to vote on a bill to cap monthly insulin costs, but many lobbyists consider insulin cost caps a policy that appeases voters without curbing prices for even insulins, never mind other drugs. “For the subset of enhanced PDPs participating in the $35 copay insulin model,...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.